Hepion Pharmaceuticals Inc (HEPA)’s stock is trading at $0.15 at the moment marking a fall of -14.37% from the last session close. As of this writing, shares are priced at -95.60% less than their 52-week high of $3.49, and 27.02% over their 52-week low of $0.12. Based on the past 30-day period, the stock price is -77.63% below the high and +31.24% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, HEPA’s SMA-200 is $0.8147.
How does Hepion Pharmaceuticals Inc (HEPA) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 0 brokerage firms that recommend the stock as a Strong Sell. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 0.00 in simple terms.
Hepion Pharmaceuticals Inc (NASDAQ: HEPA) Ownership Details
I will give a breakdown of the key shareholders in Hepion Pharmaceuticals Inc (HEPA). Recent figures show that the company’s insiders hold 0.09% of shares. A total of 27 institutional investors hold shares in the company, making 7.85% of its stock and 7.85% of its float.
Sep 30, 2024, it was reported that the Company’s largest institutional holder is Anson Funds Management LP holding total of 231.85 shares that make 3.33% of the company’s total number of shares and are currently priced at 36516.0.
The securities firm Vanguard Group Inc holds 90.92 shares of HEPA, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 1.31%, and the holding percentage of shares is valued at 14320.0.
An overview of Hepion Pharmaceuticals Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Hepion Pharmaceuticals Inc (HEPA) traded 50,850,543 shares per day, with a moving average of $0.3609 and price change of -0.3358. With the moving average of $0.4949 and a price change of -0.5288, about 20,360,818 shares changed hands on average over the past 50 days. Finally, HEPA’s 100-day average volume is 10,204,063 shares, alongside a moving average of $0.5811 and a price change of -0.5912.
